Technology Press Bahrain: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Press Bahrain.

Press releases published on August 14, 2026

9 hours ago

GT Biopharma Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

9 hours ago

Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease

Indeterminate GlobeNewswire

9 hours ago

CSPi Reports FY2026 Third Quarter Results

Indeterminate GlobeNewswire

9 hours ago

Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

9 hours ago

Replimune Reports Fiscal First Quarter 2027 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

9 hours ago

Quince Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Update

Indeterminate GlobeNewswire

9 hours ago

How Appinventiv is Solving AI Adoption Challenges for Global Enterprises

Indeterminate GlobeNewswire

9 hours ago

BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base

Indeterminate GlobeNewswire

9 hours ago

Diginex Limited Announces Extraordinary General Meeting to Approve Proposed Acquisition of Resulticks

Indeterminate GlobeNewswire

9 hours ago

WRAP Selected by WOFT to Support Florida’s $475,000 Teacher Safety Training Initiative

Indeterminate GlobeNewswire

10 hours ago

Outlook Therapeutics Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™

Indeterminate GlobeNewswire

10 hours ago

Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update

Indeterminate GlobeNewswire

10 hours ago

Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update 

Indeterminate GlobeNewswire

10 hours ago

 Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress

Indeterminate GlobeNewswire

10 hours ago

Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial of FT819 for the Treatment of Lupus Nephritis

Indeterminate GlobeNewswire

10 hours ago

Medicenna Therapeutics Reports First Quarter Fiscal 2027 Financial Results and Announces Oral Presentations at Upcoming Conferences

Indeterminate GlobeNewswire

10 hours ago

JOYY to Announce Second Quarter 2026 Financial Results on August 25, 2026

Indeterminate GlobeNewswire

10 hours ago

Aurora Mobile and Exabytes Sign Three-Year Strategic MoU to Bring AI-Powered Customer Engagement to Businesses Across Southeast Asia

Indeterminate GlobeNewswire

10 hours ago

Rein Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

10 hours ago

Diginex and Resulticks Sign Amended Definitive Agreement to Create a Global AI-Powered Group Spanning Customer Engagement and Trusted Sustainability Data

Indeterminate GlobeNewswire